On June 4, Intuitive Surgical rose 3.04% in regular trading, trading at $420.38/share, with trading volume of $226 million. The stock rebounded alongside a broad recovery in the Health Care Equipment sector after weeks of selling pressure driven by multiple analyst downgrades and product recall concerns.
The Healthcare Equipment sector staged a collective rally, with Medtronic up 5.55%, Abbott Laboratories up 4.53%, Boston Scientific up 2.96%, and Stryker up 2.87%. Intuitive Surgical had previously suffered a cumulative decline of over 27% year-to-date, weighed by Goldman Sachs cutting its target price from $621 to $558 in late May and Deutsche Bank slashing its target from $440 to $366 with a sell rating in early June. Today's sector-wide recovery in sentiment provided the catalyst for an oversold bounce.
Intuitive Surgical is a global leader in robotic-assisted minimally invasive care, offering the da Vinci Surgical System and Ion endoluminal system as part of a comprehensive ecosystem spanning instrumentation, digital capabilities, and services.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments